Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

32.86
BATS BZX Real-Time Price
As of 3:53pm ET
 +0.03 / +0.09%
Today’s Change
19.31
Today|||52-Week Range
34.50
+20.68%
Year-to-Date

Today’s Trading

Previous close32.83
Today’s open32.96
Day’s range32.30 - 33.31
Volume70,020
Average volume (3 months)251,163
Market cap$1.3B
Dividend yield--
Data as of 3:39pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)+3.53%
Earnings growth (this year)+39.45%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+8.49%
P/E ratio42.5
Price/Sales3.68
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.18+0.48%
CLLSCellectis SA-0.63-1.76%
SRPTSarepta Therapeutics...+1.45+4.54%
RGENRepligen Corp+0.40+1.14%
Data as of 3:55pm ET, 08/03/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)$0.11
Annual revenue (last year)$339.3M
Annual profit (last year)$36.7M
Net profit margin10.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Rockville, Maryland

Forecasts